PD-1 and CTLA-4 are critically involved in immune checkpoints, and potential tumor-reactive lymphocytes are often restrained by CTLA- and/or PD-1-transduced signals, reflecting the ability of many cancers to upregulate the corresponding ligands [13]. Here, PDCD1 is linked to neoplasm.